Working… Menu

Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03620474
Recruitment Status : Active, not recruiting
First Posted : August 8, 2018
Last Update Posted : April 6, 2021
PRISM BioLab Co.,Ltd.
Kyushu University
National Center for Global Health and Medicine, Japan
Japan Agency for Medical Research and Development
Ohara Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Kiminori Kimura, MD, Komagome Hospital

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2022
Estimated Study Completion Date : March 2022